Reported 28 days ago
Berkshire Hathaway announced it sold 203,091 shares of DaVita, cutting its ownership in the kidney dialysis provider to approximately 35.89 million shares, which translates to a 45% stake valued at nearly $6.4 billion. This adjustment was part of a share repurchase agreement requiring DaVita to buy back shares to maintain Berkshire's stake at this level.
Source: YAHOO